Skip to main content
Scheme 1 | EJNMMI Radiopharmacy and Chemistry

Scheme 1

From: Chelator impact: investigating the pharmacokinetic behavior of copper-64 labeled PD-L1 radioligands

Scheme 1

Synthesis of key amine intermediate 13. a 3, K2CO3, abs. DMF, r.t., 16 h, 81%; b, abs. DMF/MeOH (1:1), r.t., 16 h, 41%; c DMEAD, PPh3, abs. DMF/THF (1:1), 0 °C to r.t., 16 h, 65%; d l-cysteic acid, NaBH3CN, abs. DMF/MeOH (1:1), r.t., 16 h, 41%; e taurine, HATU, HOBt, DIPEA, abs. DMF, r.t., 2 h, 70%; f 11, sodium ascorbate, CuSO4, THPTA, tBuOH/H2O (1:1), r.t., 16 h, 78%; g NaN3, abs. DMF, 50 °C, 3 h, 60%

Back to article page